An overview of complications associated with deferoxamine therapy in thalassemia

• Main Authors: Bijan Keikhaei (Author), Neda Farmani-Anooshe (Author), Mohammad Bahadoram (Author), Mohammad-Reza Mahm (Author), Kosar Alikhani (Author), Ammar Helalinasab (Author)
• Format: Book
• Published: Society of Diabetic Nephropathy Prevention, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Thalassemic syndromes are the most common genetic diseases in the world that are related to blood transfusion and iron overload in the body. In ß-thalassemia major multiple blood transfusions due to ineffective erythropoiesis lead to iron excess in the body. Iron chelating agent deferoxamine is used...